The Cancer Cytogenetics Laboratory at the University Health Network (Toronto) started a pilot program nearly one year ago to test the feasibility of replacing karyotyping and FISH assays with Optical ...
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2–Activating Mutations: Results From the National Cancer Institute–Molecular Analysis for Therapy Choice ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results